GENEMATRIX INC. Logo

GENEMATRIX INC.

Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.

109820 | KO

Overview

Corporate Details

ISIN(s):
KR7109820001
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로 700 삼평동 코리아바이오파크 8층,7층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GeneMatrix Inc. is a biomedical company specializing in multiplex molecular diagnostics. Founded in 2000, the company develops innovative diagnostic products based on its core multiplex real-time PCR platform technology. Its flagship NeoPlex™ product line features assays designed for the simultaneous detection of multiple pathogens from a single sample, offering fast, accurate, and cost-effective solutions for various infectious diseases, including respiratory illnesses, HPV, and tuberculosis. Alongside its focus on diagnostics, GeneMatrix also engages in the development of new drugs and therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 815.6 KB
2025-06-16 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획자진취하등) (GMJI-01의 국내 제1상 임상시험계획 승인신청 자진취하)
Korean 13.9 KB
2025-06-02 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 881.6 KB
2025-04-21 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청등결정) (GMAI-02의 국내 제1상 임상시험계획승인)
Korean 13.4 KB
2025-04-14 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.0 KB
2025-04-02 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.2 KB
2025-04-02 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.0 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.4 KB
2025-03-21 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.8 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 18.2 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 332.8 KB
2025-03-10 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.8 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 13.3 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.5 KB

Automate Your Workflow. Get a real-time feed of all GENEMATRIX INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENEMATRIX INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENEMATRIX INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Lexaria Bioscience Corp. Logo
Biotech firm with patented technology improving oral drug delivery and absorption.
United States of America
LEXX
Lexeo Therapeutics, Inc. Logo
Develops AAV gene therapies for genetic cardiovascular and Alzheimer's diseases.
United States of America
LXEO
LEXICON PHARMACEUTICALS, INC. Logo
Develops gene-based drugs for chronic diseases, including treatments for heart failure.
United States of America
LXRX
LIFECORE BIOMEDICAL, INC. \DE\ Logo
A CDMO for parenteral drugs, producing injectable-grade sodium hyaluronate (HA).
United States of America
LFCR
Liminatus Pharma, Inc. Logo
Clinical-stage immuno-oncology firm developing cancer therapies targeting the CD47 checkpoint.
United States of America
LIMN
Lineage Cell Therapeutics Inc. Logo
Developing off-the-shelf cell therapies for neurological and ophthalmic conditions.
Israel
LCTX
Lipigon Pharmaceuticals AB Logo
Develops novel drugs for lipid metabolism disorders to reduce cardiovascular disease risk.
Sweden
LPGO
Lipocine Inc. Logo
Biopharma developing oral drugs for metabolic & endocrine disorders using delivery technology.
United States of America
LPCN
Lipum AB Logo
Develops first-in-class antibody treatments for chronic inflammatory diseases like arthritis.
Sweden
LIPUM
Liquidia Corp Logo
Develops inhaled therapies for rare cardiopulmonary diseases using proprietary PRINT® technology.
United States of America
LQDA

Talk to a Data Expert

Have a question? We'll get back to you promptly.